Heart radiation zaps deadly rhythms: 4-Year study launches

NCT ID NCT06744530

Recruiting now Disease control Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 50 patients with ventricular tachycardia that hasn't responded to standard treatments. They receive a single, high-dose radiation treatment (STAR) aimed at the heart tissue causing the abnormal rhythm. Researchers will track how well the treatment controls the heart rhythm and whether it improves quality of life over 48 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: stereotactic radiotherapy ablation (STAR)
What this could lead to: If successful, this could confirm STAR as a safe and effective long-term option for controlling life-threatening heart rhythm problems when other treatments fail.
What could go wrong: This is an observational study with no control group, so results may not prove STAR is better than alternatives. Long-term side effects from heart radiation are still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA (VT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR TACHYCARDIA (VT)

Contacts and locations

Locations

UZ Leuven
RECRUITING

Leuven, 3000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.